Submission Instructions

 


To submit your abstract
Step 1: Create your profile and login here.
Step 2: Once your profile has been created and you have successfully logged into the submission site, you may select the Submissions tab and proceed to fill in the submissions form.

 
Editing a submission
You may edit your abstract after submission up to the submission deadline April 14, 2020.
To edit your abstract, login to the submission site with your email and password, to access your submission(s)
 

General Guidelines

Submission of an abstract acknowledges your consent to the following:
  • If accepted, your abstract may be published in the Haemophilia journal supplement.
  • If accepted as an oral presentation, your PowerPoint presentation may be posted on the WFH website, on-site and post conference.
  • If accepted as a poster presentation, you will display your poster at the Congress.

Late-breaking Abstract Submission and Review Timeline

 The deadline for late-breaking abstract submission is April 14, 2020 at 11:59PM EST. The status of the peer review will be announced the week of April 27, 2020. The submitter will be notified by email.
 
 

Author Information

During the abstract process, you will be asked to enter author information and affiliations. Please list the authors in your preferred citation order. If you are submitting supporting graphs or tables, please do NOT include the author list in the Word document, as we operate by blind review. 
 
 
Presenting Author Registration
 
A presenting author must be designated to attend the congress and present the submitted abstract, should it be accepted. Presenting Authors (for both orals and posters) must register to attend the World Congress 2020. If the Presenting Author is not registered by the registration deadline of May 8, 2020, the abstract will not be included in the final program.
 
 
Disclosure of potential Conflict of Interest

If an author or immediate family member has had a substantial financial relationship relating to the support of the abstract, this relationship must be disclosed. Such relationships include salaries, ownership, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process you will be asked to disclose any potential conflicts of interest.
 
 
Language of Abstract
Your abstract must be submitted in English
 
 
Number of Submissions
 
Each author may present a maximum of two abstracts at the Congress. The number of submissions is, however, unlimited. Should an author have more than two abstracts accepted a co-author must be named as presenting author for the additional abstracts.
 
 
Presentation Format
 
During the abstract submission, you will be asked your preferred format:
  • Free Paper (oral presentation)
  • Poster
 Authors selecting free paper may be offered a poster presentation if not selected for an oral.
 
 
Title and Abstract Length
 
Abstracts should be no more than 350 words in length; the title is not included in the word count. Please use Title Case (capital letters to start the principal words) for you abstract title instead of all CAPITAL or all small letters. Please note that abstracts which exceed the word limit may be excluded from the program. Data tables will count as 50 words toward the 350 word limit.
 
 
Submission Format
Your abstract requires a minimum of 4 sections (e.g. Introduction and Objectives/ Material and Methods/ Results/ Conclusions). You will be able to list your own headings.
On the submission form, copy/paste your abstract into the respective sections. A separate field will be available to list the title.
Should you have supporting tables or graphs, you will have the option to upload them in a Word document format. 
 
 
Formatting
  • Use a short, specific title. The title should be entered in sentence case. Do not use a period at the end of the title and do not place the title in quotes nor use ALL CAPS.
  •  Capitalize the first letter of trade names.
  • Do NOT use ALL CAPS in the title or in the body text. 
  • Use standard abbreviations for units of measure; other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parenthesis (exceptions: RNA, DNA, etc.).
  • Special Characters: Please use the special character palette if you need to use a special character. If you copy and paste your abstract, please be sure to enter special characters using the palette, even if they seem to appear correctly after pasting. If you do not use the special palette, your special characters will not appear properly in publication. Please be sure to double-check during the proofreading step to ensure all special characters were converted properly.